According to some embodiments of the present disclosure, an adaptor configured to couple with a sealed vial can include a connector interface. The adaptor can include one or more access channels (e.g., passages). In some cases the one or more access channels are in fluid communication with the connector interface. The adaptor can include a piercing member. The piercing member can include a regulator channel. The adaptor can include a regulator assembly. The regulator assembly can include a first regulator inlet. In some cases, the regulator includes a second regulator inlet. One or more of the first and second regulator inlets can include a filter configured to filter fluid passing into and/or out of the respective regulator inlets. One or more valves can be positioned between the first and/or second regulator inlets and the piercing member.
According to some variants, an adaptor configured to couple with a sealed vial can include a connector interface. In some embodiments, the adaptor includes an access channel. The access channel can be in fluid communication with the connector interface. In some cases, the adaptor includes a regulator assembly. The regulator assembly can include a first regulator inlet. The first regulator inlet can be in fluid communication with an ambient environment surrounding the adaptor. In some embodiments, the regulator assembly includes a first regulator lumen. In some cases, the regulator assembly includes a second regulator inlet. The second regulator inlet can be in fluid communication with the ambient environment. In some cases, the regulator assembly includes a second regulator lumen. In some embodiments, the regulator assembly includes a first filter. The first filter can be capable of fluid communication with the first regulator lumen. In some embodiments, the first filter is configured to filter fluid passing into the first regulator lumen. The regulator assembly can include a second filter. The second filter can be in fluid communication with the second regulator lumen. In some embodiments, the second filter is configured to filter fluid passing from the second regulator lumen and into the ambient environment. In some embodiments, the regulator assembly includes a regulator valve. The regulator valve can be in fluid communication with the first regulator lumen. In some embodiments, the regulator valve is configured to permit passage of fluid from the ambient environment into the first regulator lumen. In some cases, the regulator valve is configured to prevent passage of fluid from within the vial to the first filter. The adaptor can include a piercing member. The piercing member can include a proximal end and a distal end. In some embodiments, the distal end comprises a piercing tip. In some cases, the adaptor includes a regulator channel. The regulator channel can be positioned at least partially within the piercing member. In some embodiments, the regulator channel includes a first regulator channel opening in fluid communication with the first regulator lumen. In some embodiments, the adaptor can be used in conjunction with a sealed vial.
In some embodiments, the regulator valve comprises a valve stem and/or a flap portion. In some cases, the flap portion comprises a concave side and/or a convex side. In some embodiments, the first regulator lumen and the second regulator lumen are in fluid communication with each other. In some configurations, the regulator valve is positioned in a plug portion. In some cases, the plug portion can be inserted into the regulator lumen. In some embodiments, the plug portion is flexible. In some embodiments, the plug portion is retained within the regulator lumen (e.g., by a friction fit). In some cases, a cap portion limits the extent to which the plug portion is inserted into the regulator lumen. In some embodiments, the first filter is positioned in the plug portion. In some cases, the first filter is positioned within the first regulator lumen. In some embodiments, the second filter is positioned within the second regulator lumen. In some cases, the first and second filters are positioned along a common line. In some embodiments, the common line is generally perpendicular to the regulator channel. In some cases, the regulator valve is positioned along the common line.
According to some variants, a method of manufacturing a vial adaptor can include providing a connector interface. In some embodiments, the method includes providing an access channel. The access channel can be in fluid communication with the connector interface. The method can include providing a regulator assembly. The regulator assembly can include a first regulator inlet. The first regulator include can be in fluid communication with an ambient environment surrounding the adaptor. In some cases, the regulator assembly includes a second regulator inlet. The second regulator inlet can be in fluid communication with the ambient environment. The regulator assembly can include a first filter. The first filter can be configured to filter fluid passing into the vial adaptor. In some embodiments, the regulator assembly includes a second filter. The second filter can be configured to filter fluid passing from the vial adaptor into the ambient environment. In some cases, the regulator assembly includes a regulator valve. The regulator valve can be configured to permit passage of fluid from the ambient environment into the vial adaptor. In some embodiments, the regulator valve is configured to inhibit passage of fluid from within the vial to the first filter. The method can include providing a piercing member. The piercing member can include a proximal end and a distal end. In some cases, the distal end includes a piercing tip. In some embodiments, the method includes providing a regulator channel. The regulator channel can be positioned at least partially within the piercing member. In some embodiments, the regulator channel includes a first regulator channel opening. In some cases, the regulator channel is in fluid communication with the second filter and/or with the regulator valve. In some embodiments, the first and second regulator inlets are provided along a common line that is generally perpendicular to the regulator channel. In some cases, the regulator valve is providing along the common line. In some embodiments, the regulator valve is configured to prevent passage of fluid from within the vial to the first filter. In some cases, the regulator valve comprises a valve stem and/or a flap portion. In some embodiments, the flap portion has a concave side and/or a convex side
Certain embodiments disclosed herein relate to adaptors for coupling with medicinal vials, and components thereof, and methods to contain vapors and/or to aid in regulating pressures within medicinal vials.
It is a common practice to store medicines or other medically related fluids in vials or other containers. In some instances, the medicines or fluids so stored are therapeutic if injected into the bloodstream, but harmful if inhaled or if contacted by exposed skin. Certain known systems for extracting potentially harmful medicines from vials suffer from various drawbacks.
Various embodiments are depicted in the accompanying drawings for illustrative purposes, and should in no way be interpreted as limiting the scope of the embodiments. In addition, any features of different disclosed embodiments can be combined to form additional embodiments, which are part of this disclosure.
In general, the container 10 is hermetically sealed to preserve the contents of the container 10 in a sterile environment. The container 10 can be evacuated or pressurized upon sealing. In some instances, the container 10 is partially or completely filled with a liquid, such as a drug or other medical fluid. In such instances, one or more gases can also be sealed in the container 10. In some instances, a solid or powdered substance, such as a lyophilized pharmaceutical, is disposed in the container 10.
The accessor 20 generally provides access to contents of the container 10 such that the contents may be removed or added to. In certain arrangements, the accessor 20 includes an opening between the interior and exterior of the container 10. The accessor 20 can further comprise a passageway between the interior and exterior of the container 10. In some configurations, the passageway of the accessor 20 can be selectively opened and closed. In some arrangements, the accessor 20 comprises a conduit extending through a surface of the container 10. The accessor 20 can be integrally formed with the container 10 prior to the sealing thereof or introduced to the container 10 after the container 10 has been sealed.
In some configurations, the accessor 20 is in fluid communication with the container 10, as indicated by an arrow 21. In certain of these configurations, when the pressure inside the container 10 varies from that of the surrounding environment, the introduction of the accessor 20 to the container 10 causes a transfer through the accessor 20. For example, in some arrangements, the pressure of the environment that surrounds the container 10 exceeds the pressure within the container 10, which may cause ambient air from the environment to ingress through the accessor 20 upon insertion of the accessor 20 into the container 10. In other arrangements, the pressure inside the container 10 exceeds that of the surrounding environment, causing the contents of the container 10 to egress through the accessor 20.
In some configurations, the accessor 20 is coupled with an exchange device 40. In certain instances, the accessor 20 and the exchange device 40 are separable. In some instances, the accessor 20 and the exchange device 40 are integrally formed. The exchange device 40 is configured to accept fluids and/or gases from the container 10 via the accessor 20, to introduce fluids and/or gases to the container 10 via the accessor 20, or to do some combination of the two. In some arrangements, the exchange device 40 is in fluid communication with the accessor 20, as indicated by an arrow 24. In certain configurations, the exchange device 40 comprises a medical instrument, such as a syringe.
In some instances, the exchange device 40 is configured to remove some or all of the contents of the container 10 via the accessor 20. In certain arrangements, the exchange device 40 can remove the contents independent of pressure differences, or lack thereof, between the interior of the container 10 and the surrounding environment. For example, in instances where the pressure outside of the container 10 exceeds that within the container 10, an exchange device 40 comprising a syringe can remove the contents of the container 10 if sufficient force is exerted to extract the plunger from the syringe. The exchange device 40 can similarly introduce fluids and/or gases to the container 10 independent of pressure differences between the interior of the container 10 and the surrounding environment.
In certain configurations, the regulator 30 is coupled with the container 10. The regulator 30 generally regulates the pressure within the container 10. As used herein, the term “regulate,” or any derivative thereof, is a broad term used in its ordinary sense and includes, unless otherwise noted, any active, affirmative, or positive activity, or any passive, reactive, respondent, accommodating, or compensating activity that tends to effect a change. In some instances, the regulator 30 substantially maintains a pressure difference, or equilibrium, between the interior of the container 10 and the surrounding environment. As used herein, the term “maintain,” or any derivative thereof, is a broad term used in its ordinary sense and includes the tendency to preserve an original condition for some period, with some small degree of variation permitted as may be appropriate in the circumstances. In some instances, the regulator 30 maintains a substantially constant pressure within the container 10. In certain instances, the pressure within the container 10 varies by no more than about 1 psi, no more than about 2 psi, no more than about 3 psi, no more than about 4 psi, or no more than about 5 psi. In still further instances, the regulator 30 equalizes pressures exerted on the contents of the container 10. As used herein, the term “equalize,” or any derivative thereof, is a broad term used in its ordinary sense and includes the tendency for causing quantities to be the same or close to the same, with some small degree of variation permitted as may be appropriate in the circumstances. In certain configurations, the regulator 30 is coupled with the container 10 to allow or encourage equalization of a pressure difference between the interior of the container 10 and some other environment, such as the environment surrounding the container 10 or an environment within the exchange device 40. In some arrangements, a single device comprises the regulator 30 and the accessor 20. In other arrangements, the regulator 30 and the accessor 20 are separate units.
The regulator 30 is generally in communication with the container 10, as indicated by an arrow 31, and a reservoir 50, as indicated by another arrow 35. In some configurations, the reservoir 50 comprises at least a portion of the environment surrounding the container 10. In some cases, the reservoir 50 is the ambient environment surrounding the container 10.
In certain embodiments, the regulator 30 provides fluid communication between the container 10 and the reservoir 50. In certain of such embodiments, the fluid in the reservoir 50 (e.g., in the surrounding environment) includes mainly gas so as not to appreciably dilute liquid contents of the container 10. In some arrangements, the regulator 30 comprises a filter to purify or remove contaminants from the gas or liquid entering the container 10, thereby reducing the risk of contaminating the contents of the container 10. In certain arrangements, the filter is hydrophobic such that air can enter the container 10 but fluid cannot escape therefrom. In some configurations, the regulator 30 comprises an orientation-actuated or orientation-sensitive check valve which selectively inhibits fluid communication between the container 10 and the filter. In some configurations, the regulator 30 comprises a check valve which selectively inhibits fluid communication between the container 10 and the filter when the valve and/or the container 10 are oriented so that the regulator 30 is held above (e.g., further from the floor than) the regulator 30.
As schematically illustrated in
In certain embodiments, the accessor 20 is in fluid communication with the container 10. In further embodiments, the accessor 20 is in fluid communication with the exchange device 40, as indicated by the arrow 24.
The regulator 30 can be in fluid or non-fluid communication with the container 10. In some embodiments, the regulator 30 is located entirely outside the container 10. In some embodiments, the regulator 30 is in communication, either fluid or non-fluid, with the reservoir 50, as indicated by the arrow 35.
As schematically illustrated in
The accessor 20 can be in fluid communication with the container 10, as indicated by the arrow 21. In some embodiments, the accessor 20 can be in fluid communication with the exchange device 40, as indicated by the arrow 24.
In certain embodiments, the regulator 30 can be in fluid or non-fluid communication with a valve 25, as indicated by the arrow 32. In some embodiments, the valve 25 can be integrally formed with the container 10 or separate therefrom. In some embodiments, the valve 25 can be integrally formed with the regulator 30 or separate therefrom. In certain embodiments, the valve 25 can be in fluid or non-fluid communication with the container 10, as indicated by the arrow 33.
In some embodiments the regulator 30 can be in fluid or non-fluid communication with the reservoir 50 (e.g., the ambient surroundings), as indicated by the arrow 35A.
According to some configurations, the regulator 30 can comprise a filter. In some embodiments, the filter can selectively inhibit passage of liquids and/or contaminants between the valve 25 and the reservoir 50. In some embodiments, the filter can selectively inhibit passage of liquids and/or contaminants between the reservoir 50 and the valve 25.
In some embodiments, the valve 25 can be a one-way check valve. In some embodiments, the valve 25 can be a two-way valve. According to some configurations, the valve 25 can selectively inhibit liquid communication between the filter and/or reservoir 50 and the container 10.
As illustrated in
In certain embodiments, the adaptor 100 (e.g., a vial adaptor) comprises a piercing member 120, a cap connector 130, a connector interface 140, and a regulator assembly 150. Further details and examples regarding some embodiments of piercing members 120, cap connectors 130, and connector interfaces 140 are provided in U.S. Patent Application Publication No. 2009/0216212, the entirety of each of which is incorporated herein by reference and is made a part of this specification. For clarity, a vial is not illustrated. The adaptor 100 can mate with the vial in a similar manner as illustrated and described in U.S. patent application Ser. No. 14/179,475, filed Feb. 12, 2014, the entirety of which is incorporated herein by reference and is made a part of this specification. For example, when the adaptor 100 is mated with the vial, the piercing member 120 extends through a septum of the vial into the interior of the vial.
In some embodiments, such as in the illustrated embodiment, the cap connector 130 comprises a central portion 132 (that can be curved) and one or more tabs 134 (which can be opposing) attached to the central portion 132. Each of the tabs 134 can be supported at a proximal end of the tab 134 by the central portion 132 of the body portion 380. As shown, the distal end of the tabs 134 can each be unrestrained so as to allow the tab to deflect outward. As used herein the term, “proximal,” or any derivative thereof, refers to a direction along the axial length of the piercing member 120 that is toward the connector interface 140; the term “distal,” or any derivative thereof, indicates the opposite direction.
The cap connector 130, including the central portion 132 and tabs 134, can help removably secure the vial adaptor 100 to the outside surface of the vial and can help facilitate the removal of the vial adaptor 100 from the vial. In some embodiments, the cap connector 130 comprises only one tab 134, as opposed to a pair of opposing tabs 134, the single tab being configured to removably secure the vial adaptor 300 to the outside surface of the vial and to facilitate the removal of the vial adaptor 100 from the vial. The single tab 134 can be of any suitable configuration, including those set forth herein.
As illustrated in
As illustrated in
Referring to
As illustrated in
Referring to
The regulator housing 158 can comprise a first regulator lumen 160. In some embodiments, the first regulator lumen 160 extends between the first regulator inlet 154 and the access channel wall 142. As illustrated, the first regulator lumen 160 can be in fluid communication with a regulator channel 162. The regulator channel 162 can extend at least partially through the piercing member 120. For example, the regulator channel 162 can extend between the first regulator lumen 160 and a distal regulator aperture 164. The distal regulator aperture 164 can be positioned at or near the piercing tip 122 of the piercing member 120. In some embodiments, the regulator channel 162 extends substantially parallel to the interface centerline 142.
In some embodiments, the regulator housing 158 comprises a second regulator lumen 182. The second regulator lumen 182 can extend between the second regulator inlet 156 and the access channel wall 142. In some cases, the second regulator lumen 182 is in fluid communication with one or more of the first regulator lumen 160 and the regulator channel 162. For example, as illustrated in
As illustrated in
In some embodiments, the plug portion 168 includes a hollow interior. The hollow interior of the plug portion 168 can comprise a first filter chamber 172. The first filter chamber 172 can be configured to receive a first filter 174. The first filter 174 can be adhered to or otherwise affixed to an interior of the plug portion 168 within the filter chamber 172. The filter 174 can inhibit or prevent passage of liquid and/or microbials past the filter 174. For example, the filter 174 can be hydrophobic and/or antimicrobial. In some embodiments, as shown in
As illustrated in
As illustrated in
The regulator valve 186 can include a valve body 188. The valve body 188 can be configured to releasably mate with or fixedly mate with a valve seat 190. In some embodiments, at least a portion of the valve body 188 comprises an elastomeric, resilient, and/or flexible material. For example, the valve body 188 can be injection molded using an elastomeric material.
The valve body 188 can include a flap portion 191. The flap portion 191 can have a concave side 191a and a convex side 191b. In some embodiments, the flap portion 191 can have a generally circular shape, rectangular shape, oval shape, or other suitable shape. The flap portion 191 can extend outward from (e.g., radially outward with respect to the regulator centerline 152) a hub portion 189 of the valve body 186. In some embodiments, the flap portion includes a lip portion 193. The lip portion 193 can be positioned at or near a periphery of the flap portion 191.
In some embodiments, as shown, the flap portion 191 can be configured to produce a restoring force when the flap portion 191 is temporarily moved away from its natural concave or convex configurations (e.g., such as when the flap portion 191 is caused to become substantially flat, or less concave or less convex than in its natural position, or to essentially reverse its natural concave or convex sides) to bias the flap portion 191 back to its original shape and/or orientation. In some embodiments of this configuration, the flap portion 191 can temporarily permit the passage of fluid flow that exceeds a threshold pressure from the concave side of the flap portion 191 toward the convex side of the flap portion 191, but the flat portion 191 can resist, impede, or prevent the passage of fluid flow from the convex side of the flap portion 191 toward the concave side of the flap portion, even at extremely high pressure within the context of a vascular medical product.
In some embodiments, the valve seat 190 includes a valve stem 194. The valve stem 194 can have a first end 194a and a second end 194b. The valve stem 194 can extend from the flap portion 191 (e.g., from the concave side 191a of the flap portion 191). For example, the first end 194a can be connected to the hub portion 189 of the valve body 188 and the second end 194b of the valve body 188 can be spaced from the hub portion 189. The valve stem 194 can include a valve anchor 196. The valve anchor 196 can be, for example, one or more protrusions (e.g., an annular protrusion) or other features configured to inhibit accidental de-coupling between the valve body 188 and the valve seat 190. In some embodiments, the valve anchor 196 is positioned at or near the second end 194b of the valve stem 194.
In some cases, the valve seat 190 is formed as a portion of the regulator cap 166. As illustrated in
The stop portion 200 or some other portion of the valve seat 190 or of the regulator cap 166 can include a seat aperture 202. The seat aperture 202 can have a cross-sectional shape configured to receive at least a portion of the valve stem 194. The stop portion 200 can have a thickness (e.g., as measured substantially parallel to the regulator centerline 152 in
In some embodiments, the valve stem 194 includes a flexibility-increasing feature. For example, the valve stem 194 can include a cored portion 204. The cored portion 204 can increase the compressibility of the valve stem 194. In some embodiments, the cored portion 204 can increase a sealing force between the valve stem 194 and the seat aperture 202. For example, the cored portion 204 can facilitate insertion of a valve stem 194 having a larger width (e.g., diameter) than would otherwise be capable of insertion into the seat aperture 202.
As illustrated in
The regulator assembly 150 can be configured to regulate pressure within the vial when compounds (e.g., liquids, gases, and/or solids) are introduced into or withdrawn from the vial. For example, introduction of a compound into the vial via the access channel 142 can increase the pressure within the vial. The regulator assembly 150 can be configured to release at least a portion of the excess pressure (e.g., the pressure above ambient pressure) by, for example, releasing gas from the vial through the second regulator inlet 156 via the regulator channel 162. As shown in
In some cases, the regulator assembly 150 can be configured to relieve pressure deficits within the vial. For example, withdrawing compounds from the vial via the access channel 142 can decrease the pressure within the vial. Decreased pressure within the vial can create a vacuum in the first regulator lumen 160 and/or in the second regulator lumen 176. The regulator assembly 150 can be configured to introduce ambient air (e.g., filtered ambient air) into the vial when a vacuum is created in the first and/or second regulator lumens 160, 176. For example, the regulator assembly 130 can draw ambient air into the vial via the second regulator inlet 156, through second filter 178, and/or through the regulator channel 162. In some cases (e.g., when the second regulator inlet 156 is partially or fully blocked or clogged), creation of a vacuum in the first regulator lumen 160 between the regulator valve 186 and the regulator channel 162 can create a pressure differential across the flap portion 191 of the regulator valve 186. For example, the pressure on the side of the flap portion 191 in communication with the first regulator inlet 154 can be approximately ambient pressure while the pressure on the side of the flap portion 191 in communication with the regulator channel 162 can be below ambient pressure. The regulator valve 186 can be configured to release the seal between the lip portion 193 of the flap portion 191 and the stop portion 200 of the valve seat 190 when the pressure differential across the flap portion 191 exceeds a threshold value (e.g., a cracking pressure). In some cases, the cracking pressure of the flap portion 191 can be greater than or equal to about 0.1 psi and/or less than or equal to about 5 psi. Release of the seal between the lip portion 193 of the flap portion 191 and the stop portion 200 of the valve seat 190 can transition the regulator valve 186 to an opened configuration. Transitioning the regulator valve 186 to the opened configuration can permit passage of air (e.g., filtered air) from the ambient surroundings into the vial. Introducing air from the ambient surroundings into the vial can increase the pressure within the vial and can reduce the pressure differential across the flap portion 191 of the regulator valve 186. Many variations are possible.
In some embodiments, the regulator valve 186 is configured to operate independent of the orientation of the valve adaptor 100. For example, the regulator valve 186 can be configured to operate in substantially the same manner whether the connector interface 140 is oriented above or below the piercing tip 122 of the piercing member 120. In some embodiments, the regulator valve 186 is configured to inhibit or prevent wetting of the first filter 174 from liquid within the vial. As explained above, the regulator valve 186 can operate as a one-way valve to permit fluid passage from the first regulator inlet 154 to the vial when the cracking pressure on the flap portion 191 of the regulator valve 186 is reached. Maintaining the first filter 174 in a dry condition can permit use of a small (e.g., small diameter) filter in the first filter chamber 172.
As illustrated in the figures of this application, including in
For expository purposes, the term “horizontal” as used herein is defined as a plane parallel to the plane or surface of the floor of the area in which the device being described is used or the method being described is performed, regardless of its orientation. The term “floor” floor can be interchanged with the term “ground.” The term “vertical” refers to a direction perpendicular to the horizontal as just defined. Terms such as “above,” “below,” “bottom,” “top,” “side,” “higher,” “lower,” “upper,” “over,” and “under,” are defined with respect to the horizontal plane.
The terms “approximately”, “about”, “generally” and “substantially” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, “generally,” and “substantially” may refer to an amount that is within less than 10% of the stated amount.
Although the vial adaptor has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the vial adaptor extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the embodiments and certain modifications and equivalents thereof. For example, some embodiments do not include a second regulator inlet 156 and, instead, regulate pressure within the vial via the first regulator inlet 154. Accordingly, it is intended that the scope of the vial adaptor herein-disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
This application is a continuation of U.S. patent application Ser. No. 15/384,078, filed Dec. 19, 2016, entitled “PRESSURE-REGULATING VIAL ADAPTORS,” which claims the benefit of International Application No. PCT/US2015/036305, filed on Jun. 17, 2015, entitled “PRESSURE-REGULATING VIAL ADAPTORS,” which claims the benefit of priority to U.S. Provisional Patent Application No. 62/014,872, filed on Jun. 20, 2014, entitled “PRESSURE-REGULATING VIAL ADAPTORS,” the entire contents of which are incorporated by reference herein and made part of this specification.
Number | Name | Date | Kind |
---|---|---|---|
2074223 | Horiuchi et al. | Mar 1937 | A |
2409734 | Bucher et al. | Oct 1946 | A |
2419401 | Hinds | Apr 1947 | A |
2668533 | Evans | Feb 1954 | A |
2673013 | Hester | Mar 1954 | A |
2852024 | Ryan | Jul 1954 | A |
2793758 | Murrish | Mar 1961 | A |
2999499 | Willet | Sep 1961 | A |
2999500 | Schurer | Sep 1961 | A |
3291151 | Loken | Dec 1966 | A |
RE26488 | Bull | Nov 1968 | E |
3542240 | Solowey | Nov 1970 | A |
3557778 | Hughes | Jan 1971 | A |
3584770 | Taylor | Jun 1971 | A |
3797521 | King | Mar 1974 | A |
3822700 | Pennington | Jul 1974 | A |
3844283 | Dabney | Oct 1974 | A |
3853157 | Madaio | Dec 1974 | A |
3923058 | Weingarten | Dec 1975 | A |
3938520 | Scislowcz et al. | Feb 1976 | A |
3940003 | Larson | Feb 1976 | A |
3941167 | Haury-Wirtz et al. | Mar 1976 | A |
3957082 | Fuson et al. | May 1976 | A |
3980082 | Miller | Sep 1976 | A |
3993063 | Larrabee | Nov 1976 | A |
4046291 | Goda | Sep 1977 | A |
4058121 | Choski et al. | Nov 1977 | A |
4143853 | Abramson | Mar 1979 | A |
4207923 | Giurtino | Jun 1980 | A |
4219021 | Fink | Aug 1980 | A |
4240433 | Bordow | Dec 1980 | A |
4240833 | Myles | Dec 1980 | A |
4253459 | Willis | Mar 1981 | A |
4262671 | Kersten | Apr 1981 | A |
4301799 | Pope, Jr. et al. | Nov 1981 | A |
4312349 | Cohen | Jan 1982 | A |
4314586 | Folkman | Feb 1982 | A |
4334551 | Pfister | Jun 1982 | A |
4349035 | Thomas et al. | Sep 1982 | A |
4376634 | Prior et al. | Mar 1983 | A |
4381776 | Latham, Jr. | May 1983 | A |
4396016 | Becker | Aug 1983 | A |
4410321 | Pearson et al. | Oct 1983 | A |
4458733 | Lyons | Jul 1984 | A |
4475915 | Sloane | Oct 1984 | A |
4493348 | Lemmons | Jan 1985 | A |
4505709 | Froning et al. | Mar 1985 | A |
4534758 | Akers et al. | Aug 1985 | A |
4564054 | Gustaysson | Jan 1986 | A |
4573993 | Hoag et al. | Mar 1986 | A |
4576211 | Valentini et al. | Mar 1986 | A |
4588403 | Weiss et al. | May 1986 | A |
4600040 | Naslund | Jul 1986 | A |
4645073 | Homan | Feb 1987 | A |
4673404 | Gustavsson | Jun 1987 | A |
4730635 | Linden | Mar 1988 | A |
4735608 | Sardam | Apr 1988 | A |
4743243 | Vaillancourt | May 1988 | A |
4768568 | Fournier et al. | Sep 1988 | A |
4785859 | Gustavsson et al. | Nov 1988 | A |
4798578 | Ranford | Jan 1989 | A |
4857068 | Kahn | Aug 1989 | A |
4929230 | Pfleger | May 1990 | A |
4981464 | Suzuki | Jan 1991 | A |
5006114 | Rogers | Apr 1991 | A |
5060704 | Rohrbough | Oct 1991 | A |
5169393 | Moorehead et al. | Dec 1992 | A |
5176673 | Marrucchi | Jan 1993 | A |
5334163 | Sinnett | Aug 1994 | A |
5349984 | Weinheimer et al. | Sep 1994 | A |
5405331 | Behnke et al. | Apr 1995 | A |
5445630 | Richmond | Aug 1995 | A |
5478337 | Okamoto et al. | Dec 1995 | A |
5580351 | Helgren et al. | Dec 1996 | A |
5660796 | Sheehy | Aug 1997 | A |
5685866 | Lopez | Nov 1997 | A |
5700245 | Sancoff et al. | Dec 1997 | A |
5725500 | Micheler | Mar 1998 | A |
5749394 | Boehmer et al. | May 1998 | A |
5766147 | Sancoff et al. | Jun 1998 | A |
5772079 | Gueret | Jun 1998 | A |
5776125 | Dudar et al. | Jul 1998 | A |
5803311 | Fuchs | Sep 1998 | A |
5833213 | Ryan | Nov 1998 | A |
5890610 | Jansen et al. | Apr 1999 | A |
6003553 | Wahlberg | Dec 1999 | A |
6071270 | Fowles et al. | Jun 2000 | A |
6139534 | Niedospial et al. | Oct 2000 | A |
6159192 | Fowles et al. | Dec 2000 | A |
6358236 | DeFoggi et al. | Mar 2002 | B1 |
6457488 | Loo | Oct 2002 | B2 |
6478788 | Aneas | Nov 2002 | B1 |
6544246 | Niedospial, Jr. | Apr 2003 | B1 |
6551299 | Miyoshi et al. | Apr 2003 | B2 |
6572256 | Seaton et al. | Jun 2003 | B2 |
6679290 | Matthews et al. | Jan 2004 | B2 |
6692478 | Paradis | Feb 2004 | B1 |
6715520 | Andreasson et al. | Apr 2004 | B2 |
6719719 | Carmel et al. | Apr 2004 | B2 |
6832994 | Niedospial, Jr. et al. | Dec 2004 | B2 |
6890328 | Fowles et al. | May 2005 | B2 |
6989002 | Guala | Jan 2006 | B2 |
6997910 | Howlett et al. | Feb 2006 | B2 |
6997917 | Niedospial, Jr. et al. | Feb 2006 | B2 |
7004926 | Navia et al. | Feb 2006 | B2 |
7048720 | Thorne, Jr. et al. | May 2006 | B1 |
7086431 | D'Antonio et al. | Aug 2006 | B2 |
7101354 | Thorne, Jr. et al. | Sep 2006 | B2 |
7140401 | Wilcox et al. | Nov 2006 | B2 |
7192423 | Wong | Mar 2007 | B2 |
7213702 | Takimoto et al. | May 2007 | B2 |
7291131 | Call | Nov 2007 | B2 |
7306584 | Wessman et al. | Dec 2007 | B2 |
7326194 | Zinger et al. | Feb 2008 | B2 |
7354427 | Fangrow | Apr 2008 | B2 |
7507227 | Fangrow | Mar 2009 | B2 |
7510547 | Fangrow | Mar 2009 | B2 |
7510548 | Fangrow | Mar 2009 | B2 |
7513895 | Fangrow | Apr 2009 | B2 |
7530546 | Ryan | May 2009 | B2 |
7534238 | Fangrow | May 2009 | B2 |
7547300 | Fangrow | Jun 2009 | B2 |
7569043 | Fangrow | Aug 2009 | B2 |
7618408 | Yandell | Nov 2009 | B2 |
7632261 | Zinger et al. | Dec 2009 | B2 |
7645271 | Fangrow | Jan 2010 | B2 |
7654995 | Warren et al. | Feb 2010 | B2 |
7658733 | Fangrow | Feb 2010 | B2 |
7678333 | Reynolds et al. | Mar 2010 | B2 |
7703486 | Costanzo | Apr 2010 | B2 |
7731678 | Tennican et al. | Jun 2010 | B2 |
7743799 | Mosler et al. | Jun 2010 | B2 |
7744580 | Reboul | Jun 2010 | B2 |
7758560 | Connell et al. | Jul 2010 | B2 |
7789871 | Yandell | Sep 2010 | B1 |
7799009 | Niedospial, Jr. et al. | Sep 2010 | B2 |
D630732 | Lev et al. | Jan 2011 | S |
7862537 | Zinger et al. | Jan 2011 | B2 |
7879018 | Zinger et al. | Feb 2011 | B2 |
7883499 | Fangrow | Feb 2011 | B2 |
7887528 | Yandell | Feb 2011 | B2 |
7900659 | Whitley et al. | Mar 2011 | B2 |
D637713 | Nord et al. | May 2011 | S |
7942860 | Horppu | May 2011 | B2 |
7963954 | Kavazov | Jun 2011 | B2 |
D641080 | Zinger et al. | Jul 2011 | S |
7972321 | Fangrow | Jul 2011 | B2 |
7975733 | Horppu et al. | Jul 2011 | B2 |
7981089 | Weilbacher | Jul 2011 | B2 |
7981101 | Walsh | Jul 2011 | B2 |
7998106 | Thorne, Jr. et al. | Aug 2011 | B2 |
8021325 | Zinger et al. | Sep 2011 | B2 |
8025653 | Capitqaine et al. | Sep 2011 | B2 |
8029747 | Helmerson | Oct 2011 | B2 |
8074964 | Mansour et al. | Dec 2011 | B2 |
8096525 | Ryan | Jan 2012 | B2 |
8100154 | Reynolds et al. | Jan 2012 | B2 |
8109285 | Ehrman et al. | Feb 2012 | B2 |
8123736 | Kraushaar et al. | Feb 2012 | B2 |
8141601 | Fehr et al. | Mar 2012 | B2 |
8156971 | Costanzo | Apr 2012 | B2 |
8162006 | Guala | Apr 2012 | B2 |
8162013 | Rosenquist et al. | Apr 2012 | B2 |
8162914 | Kraushaar et al. | Apr 2012 | B2 |
8167863 | Yow | May 2012 | B2 |
8167864 | Browne | May 2012 | B2 |
8172794 | Lum et al. | May 2012 | B2 |
8177768 | Leinsing | May 2012 | B2 |
8196614 | Kriheli | Jun 2012 | B2 |
8197459 | Jansen et al. | Jun 2012 | B2 |
8206367 | Warren et al. | Jun 2012 | B2 |
8211082 | Hasegawa et al. | Jul 2012 | B2 |
8221382 | Moy et al. | Jul 2012 | B2 |
8225826 | Horppu et al. | Jul 2012 | B2 |
8231567 | Tennican et al. | Jul 2012 | B2 |
8241265 | Moy et al. | Aug 2012 | B2 |
8262643 | Tennican | Sep 2012 | B2 |
8267127 | Kriheli | Sep 2012 | B2 |
8267913 | Fangrow | Sep 2012 | B2 |
8281807 | Trombley, III et al. | Oct 2012 | B2 |
8286936 | Kitani et al. | Oct 2012 | B2 |
8287513 | Ellstrom et al. | Oct 2012 | B2 |
8336587 | Rosenquist et al. | Dec 2012 | B2 |
8356644 | Chong et al. | Jan 2013 | B2 |
8356645 | Chong et al. | Jan 2013 | B2 |
8357137 | Yandell | Jan 2013 | B2 |
8366658 | Davis et al. | Feb 2013 | B2 |
8381776 | Horppu | Feb 2013 | B2 |
8403905 | Yow | Mar 2013 | B2 |
8409164 | Fangrow | Apr 2013 | B2 |
8409165 | Niedospial et al. | Apr 2013 | B2 |
8425487 | Beiriger et al. | Apr 2013 | B2 |
8449521 | Thorne, Jr. et al. | May 2013 | B2 |
8454579 | Fangrow, Jr. | Jun 2013 | B2 |
8469939 | Fangrow | Jun 2013 | B2 |
8506548 | Okiyama | Aug 2013 | B2 |
8511352 | Kraus et al. | Aug 2013 | B2 |
8512307 | Fangrow | Aug 2013 | B2 |
8522832 | Lopez et al. | Sep 2013 | B2 |
8523838 | Tornqvist | Sep 2013 | B2 |
8540692 | Fangrow | Sep 2013 | B2 |
8602067 | Kuhni et al. | Dec 2013 | B2 |
8608723 | Lev et al. | Dec 2013 | B2 |
8622985 | Ellstrom | Jan 2014 | B2 |
8657803 | Helmerson et al. | Feb 2014 | B2 |
8667996 | Gonnelli et al. | Mar 2014 | B2 |
8684992 | Sullivan et al. | Apr 2014 | B2 |
8684994 | Lev et al. | Apr 2014 | B2 |
8701696 | Guala | Apr 2014 | B2 |
8702675 | Imai | Apr 2014 | B2 |
8720496 | Huwiler et al. | May 2014 | B2 |
8721614 | Takemoto et al. | May 2014 | B2 |
8753325 | Lev et al. | Jun 2014 | B2 |
8795231 | Chong et al. | Aug 2014 | B2 |
8801678 | Panian et al. | Aug 2014 | B2 |
8821436 | Mosler et al. | Sep 2014 | B2 |
8827977 | Fangrow | Sep 2014 | B2 |
8864725 | Ranalletta et al. | Oct 2014 | B2 |
8864737 | Hasegawa et al. | Oct 2014 | B2 |
8870832 | Raday et al. | Oct 2014 | B2 |
8870846 | Davis et al. | Oct 2014 | B2 |
8882738 | Fangrow et al. | Nov 2014 | B2 |
8900212 | Kubo | Dec 2014 | B2 |
8910919 | Bonnal et al. | Dec 2014 | B2 |
8926554 | Okuda et al. | Jan 2015 | B2 |
8945084 | Warren et al. | Feb 2015 | B2 |
8973622 | Lopez | Mar 2015 | B2 |
8974433 | Fangrow | Mar 2015 | B2 |
8979792 | Lev et al. | Mar 2015 | B2 |
8986262 | Young et al. | Mar 2015 | B2 |
8992501 | Seifert et al. | Mar 2015 | B2 |
9005179 | Fangrow et al. | Apr 2015 | B2 |
9005180 | Seifert et al. | Apr 2015 | B2 |
9060921 | Seifert et al. | Jun 2015 | B2 |
9067049 | Panian et al. | Jun 2015 | B2 |
9072657 | Seifert et al. | Jul 2015 | B2 |
9089474 | Cederschiöld | Jul 2015 | B2 |
9089475 | Fangrow | Jul 2015 | B2 |
9107808 | Fangrow | Aug 2015 | B2 |
9132062 | Fangrow | Sep 2015 | B2 |
9132063 | Lev et al. | Sep 2015 | B2 |
9144646 | Barron, III et al. | Sep 2015 | B2 |
9198832 | Moy et al. | Dec 2015 | B2 |
9205248 | Wu et al. | Dec 2015 | B2 |
9211231 | Mansour et al. | Dec 2015 | B2 |
9278206 | Fangrow | Mar 2016 | B2 |
9345640 | Mosier et al. | May 2016 | B2 |
9345641 | Kraus et al. | May 2016 | B2 |
9351905 | Fangrow et al. | May 2016 | B2 |
9358182 | Garfield et al. | Jun 2016 | B2 |
9381135 | Reynolds et al. | Jul 2016 | B2 |
9381137 | Garfield et al. | Jul 2016 | B2 |
9381339 | Wu et al. | Jul 2016 | B2 |
9440060 | Fangrow | Sep 2016 | B2 |
9511989 | Lopez | Dec 2016 | B2 |
9572750 | Mansour et al. | Feb 2017 | B2 |
9585812 | Browka et al. | Mar 2017 | B2 |
9597260 | Ivosevic | Mar 2017 | B2 |
9610217 | Fangrow | Apr 2017 | B2 |
9615997 | Fangrow | Apr 2017 | B2 |
9662272 | Warren et al. | May 2017 | B2 |
9763855 | Fangrow et al. | Sep 2017 | B2 |
9827163 | Lopez et al. | Nov 2017 | B2 |
9895291 | Fangrow | Feb 2018 | B2 |
9931275 | Fangrow | Apr 2018 | B2 |
9931276 | Lopez | Apr 2018 | B2 |
9987195 | Fangrow | Jun 2018 | B2 |
9993390 | Seifert et al. | Jun 2018 | B2 |
9993391 | Warren et al. | Jun 2018 | B2 |
9999569 | Kriheli | Jun 2018 | B2 |
10016339 | Guala | Jul 2018 | B2 |
10022302 | Warran et al. | Jul 2018 | B2 |
10071020 | Warren et al. | Sep 2018 | B2 |
10086188 | Fangrow | Oct 2018 | B2 |
10117807 | Fangrow | Nov 2018 | B2 |
10201476 | Fangrow | Feb 2019 | B2 |
10327989 | Fangrow | Jun 2019 | B2 |
10327991 | Seifert et al. | Jun 2019 | B2 |
10327992 | Fangrow et al. | Jun 2019 | B2 |
10327993 | Fangrow et al. | Jun 2019 | B2 |
10369349 | Nelson | Aug 2019 | B2 |
10391293 | Fangrow | Aug 2019 | B2 |
10406072 | Chhikara et al. | Sep 2019 | B2 |
10688022 | Fangrow | Jun 2020 | B2 |
10806672 | Fangrow | Oct 2020 | B2 |
20020087144 | Zinger et al. | Jul 2002 | A1 |
20020095133 | Gillis et al. | Jul 2002 | A1 |
20020193777 | Aneas | Dec 2002 | A1 |
20030153895 | Leinsing | Aug 2003 | A1 |
20030216695 | Yang | Nov 2003 | A1 |
20030229330 | Hickle | Dec 2003 | A1 |
20040073169 | Amisar et al. | Apr 2004 | A1 |
20040073189 | Wyatt et al. | Apr 2004 | A1 |
20050087715 | Doyle | Apr 2005 | A1 |
20050131357 | Denton et al. | Jun 2005 | A1 |
20050148992 | Simas, Jr. et al. | Jul 2005 | A1 |
20050203481 | Orlu et al. | Sep 2005 | A1 |
20060025747 | Sullivan et al. | Feb 2006 | A1 |
20060111667 | Matsuura et al. | May 2006 | A1 |
20060149309 | Paul et al. | Jul 2006 | A1 |
20060184103 | Paproski et al. | Aug 2006 | A1 |
20060184139 | Quigley et al. | Aug 2006 | A1 |
20070093775 | Daly | Apr 2007 | A1 |
20070106244 | Mosler | May 2007 | A1 |
20070208320 | Muramatsu et al. | Sep 2007 | A1 |
20080045919 | Jakob et al. | Feb 2008 | A1 |
20080067462 | Miller et al. | Mar 2008 | A1 |
20080142388 | Whitley et al. | Jun 2008 | A1 |
20080172003 | Plishka et al. | Jul 2008 | A1 |
20080208159 | Stanus et al. | Aug 2008 | A1 |
20090057258 | Tornqvist | Mar 2009 | A1 |
20090200504 | Ryan | Aug 2009 | A1 |
20100059474 | Brandenburger et al. | Mar 2010 | A1 |
20100106129 | Goeckner et al. | Apr 2010 | A1 |
20100160889 | Smith et al. | Jun 2010 | A1 |
20100179506 | Shemesh et al. | Jul 2010 | A1 |
20100249723 | Fangrow, Jr. | Sep 2010 | A1 |
20100305548 | Kraushaar | Dec 2010 | A1 |
20110004183 | Carrez et al. | Jan 2011 | A1 |
20110062703 | Lopez et al. | Mar 2011 | A1 |
20110108158 | Huwiler et al. | May 2011 | A1 |
20110125104 | Lynn | May 2011 | A1 |
20110125128 | Nord et al. | May 2011 | A1 |
20110175347 | Okiyama | Jul 2011 | A1 |
20110184382 | Cady | Jul 2011 | A1 |
20110224611 | Lum et al. | Sep 2011 | A1 |
20110240158 | Py | Oct 2011 | A1 |
20110257621 | Fangrow | Oct 2011 | A1 |
20110264037 | Foshee et al. | Oct 2011 | A1 |
20120046636 | Kriheli | Feb 2012 | A1 |
20120059346 | Sheppard et al. | Mar 2012 | A1 |
20120067429 | Mosler et al. | Mar 2012 | A1 |
20120078091 | Suchecki | Mar 2012 | A1 |
20120078214 | Finke et al. | Mar 2012 | A1 |
20120078215 | Finke et al. | Mar 2012 | A1 |
20120109077 | Ryan | May 2012 | A1 |
20120157964 | Haimi | Jun 2012 | A1 |
20120215181 | Lee | Aug 2012 | A1 |
20120298254 | Brem et al. | Nov 2012 | A1 |
20120302986 | Brem et al. | Nov 2012 | A1 |
20130030386 | Panian et al. | Jan 2013 | A1 |
20130033034 | Trombley, III et al. | Feb 2013 | A1 |
20130035668 | Kitani et al. | Feb 2013 | A1 |
20130053814 | Mucientes et al. | Feb 2013 | A1 |
20130053815 | Mucientes et al. | Feb 2013 | A1 |
20130060226 | Fini et al. | Mar 2013 | A1 |
20130102974 | Davis et al. | Apr 2013 | A1 |
20130110053 | Yoshino et al. | May 2013 | A1 |
20130130197 | Jessop et al. | May 2013 | A1 |
20130180618 | Py | Jul 2013 | A1 |
20130190684 | Panian et al. | Jul 2013 | A1 |
20130218121 | Waller et al. | Aug 2013 | A1 |
20130226099 | Fangrow | Aug 2013 | A1 |
20130228239 | Cederschiöld | Sep 2013 | A1 |
20130306169 | Weibel | Nov 2013 | A1 |
20140020792 | Kraus et al. | Jan 2014 | A1 |
20140107588 | Fangrow | Apr 2014 | A1 |
20140124087 | Anderson et al. | May 2014 | A1 |
20140124092 | Gonnelli et al. | May 2014 | A1 |
20140150925 | Sjogren et al. | Jun 2014 | A1 |
20140261860 | Heath et al. | Sep 2014 | A1 |
20140261877 | Ivosevic et al. | Sep 2014 | A1 |
20140276649 | Ivosevic et al. | Sep 2014 | A1 |
20140358073 | Panian et al. | Dec 2014 | A1 |
20150011963 | Fangrow | Jan 2015 | A1 |
20150020920 | Lev et al. | Jan 2015 | A1 |
20150065987 | Fangrow et al. | Mar 2015 | A1 |
20150082746 | Ivosevic et al. | Mar 2015 | A1 |
20150123398 | Sanders et al. | May 2015 | A1 |
20150126958 | Sanders et al. | May 2015 | A1 |
20150157848 | Wu et al. | Jun 2015 | A1 |
20150202121 | Seifert et al. | Jul 2015 | A1 |
20150209230 | Lev et al. | Jul 2015 | A1 |
20150209233 | Fukuoka | Jul 2015 | A1 |
20150250680 | Browka et al. | Sep 2015 | A1 |
20150250681 | Lev et al. | Sep 2015 | A1 |
20150265500 | Russo et al. | Sep 2015 | A1 |
20150297451 | Marici et al. | Oct 2015 | A1 |
20150297453 | Kim et al. | Oct 2015 | A1 |
20150297454 | Sanders et al. | Oct 2015 | A1 |
20150297456 | Marici et al. | Oct 2015 | A1 |
20150297459 | Sanders et al. | Oct 2015 | A1 |
20150297461 | Fangrow | Oct 2015 | A1 |
20150297817 | Guala | Oct 2015 | A1 |
20150297839 | Sanders et al. | Oct 2015 | A1 |
20150320642 | Fangrow | Nov 2015 | A1 |
20150320992 | Bonnet et al. | Nov 2015 | A1 |
20150359709 | Kriheli et al. | Dec 2015 | A1 |
20150366758 | Noguchi et al. | Dec 2015 | A1 |
20160000653 | Kramer | Jan 2016 | A1 |
20160008534 | Cowan et al. | Jan 2016 | A1 |
20160038373 | Ohlin | Feb 2016 | A1 |
20160038374 | Merhold et al. | Feb 2016 | A1 |
20160051446 | Lev et al. | Feb 2016 | A1 |
20160058667 | Kriheli | Mar 2016 | A1 |
20160081878 | Marks et al. | Mar 2016 | A1 |
20160081879 | Garfield et al. | Mar 2016 | A1 |
20160101020 | Guala | Apr 2016 | A1 |
20160106970 | Fangrow | Apr 2016 | A1 |
20160120753 | Warren | May 2016 | A1 |
20160120754 | Warren | May 2016 | A1 |
20160136051 | Lavi | May 2016 | A1 |
20160136412 | McKinnon et al. | May 2016 | A1 |
20160206511 | Garfield et al. | Jul 2016 | A1 |
20160206512 | Chhikara et al. | Jul 2016 | A1 |
20160213568 | Mansour et al. | Jul 2016 | A1 |
20160250102 | Garfield et al. | Sep 2016 | A1 |
20160262981 | Carrez et al. | Sep 2016 | A1 |
20160262982 | Cederschiold | Sep 2016 | A1 |
20160338911 | Fangrow | Nov 2016 | A1 |
20170095404 | Fangrow | Apr 2017 | A1 |
20170196772 | Seifert | Jul 2017 | A1 |
20170196773 | Fangrow | Jul 2017 | A1 |
20170202744 | Fangrow | Jul 2017 | A1 |
20170202745 | Seifert | Jul 2017 | A1 |
20170239140 | Fangrow | Aug 2017 | A1 |
20170258682 | Kriheli | Sep 2017 | A1 |
20170296431 | Fangrow | Oct 2017 | A1 |
20170312176 | Fangrow | Nov 2017 | A1 |
20170333288 | Fangrow | Nov 2017 | A1 |
20180028402 | Kriheli et al. | Feb 2018 | A1 |
20180099137 | Fangrow | Apr 2018 | A1 |
20180125759 | Fangrow | May 2018 | A1 |
20180161245 | Kriheli | Jun 2018 | A1 |
20180193227 | Marci et al. | Jul 2018 | A1 |
20180207063 | Lopez et al. | Jul 2018 | A1 |
20180221572 | Schlitt et al. | Aug 2018 | A1 |
20180250195 | Fangrow | Sep 2018 | A1 |
20180280240 | Fangrow | Oct 2018 | A1 |
20190000717 | Fangrow | Jan 2019 | A1 |
20190001114 | Fangrow | Jan 2019 | A1 |
20190254926 | Seifert | Aug 2019 | A1 |
20190269900 | Fangrow | Sep 2019 | A1 |
20190350812 | Chhikara | Nov 2019 | A1 |
20190358125 | Chhikara | Nov 2019 | A1 |
20200069519 | Fangrow | Mar 2020 | A1 |
20200069520 | Fangrow | Mar 2020 | A1 |
20200093695 | Seifert | Mar 2020 | A1 |
20200337948 | Fangrow | Oct 2020 | A1 |
Number | Date | Country |
---|---|---|
2013200393 | Feb 2013 | AU |
1037428 | Aug 1978 | CA |
0 829 250 | Mar 1998 | EP |
2 000 685 | Jan 1979 | GB |
39-17386 | Aug 1961 | JP |
45-20604 | Aug 1970 | JP |
57-208362 | Dec 1982 | JP |
H02-193677 | Jul 1990 | JP |
H06-66682 | Sep 1994 | JP |
2015-077217 | Apr 2015 | JP |
WO 1984004673 | Dec 1984 | WO |
WO 199702853 | Jan 1997 | WO |
WO 2000035517 | Jun 2000 | WO |
WO 2005065626 | Jul 2005 | WO |
WO 2008036101 | Mar 2008 | WO |
WO 2008153459 | Dec 2008 | WO |
WO 2008153460 | Dec 2008 | WO |
WO 2009097146 | Aug 2009 | WO |
WO 2010069359 | Jun 2010 | WO |
WO 2010093581 | Aug 2010 | WO |
WO 2010120953 | Oct 2010 | WO |
WO 2013104736 | Jul 2013 | WO |
WO 2013134246 | Sep 2013 | WO |
WO 2014116602 | Jul 2014 | WO |
WO 2015029018 | Mar 2015 | WO |
WO 2016147178 | Sep 2016 | WO |
WO 2018064206 | Apr 2018 | WO |
WO 2018186361 | Oct 2018 | WO |
Entry |
---|
Clave—NeedleFree Connector, 2-page brochure. Jan. 2012 ICU Medical, Inc. (M1-1065 Rev. 04). |
Equashield, Hazardous Drugs Closed System Transfer Device. Two webpages: http:/www.equashield.com, downloaded Jul. 22, 2013. |
Genie—Closed Vial Access Device, 2-page brochure. Jan. 2012 ICU Medical, Inc. (M1-1186 Rev. 11). |
International Search Report and Written Opinon dated Aug. 31, 2015, re PCT Application No. PCT/US2015-036305. |
International Preliminary Report on Patentability dated Dec. 20, 2016, re PCT Application No. PCT/US2015/036305. |
OnGuard Contained Medication System with Tevadaptor Components, B. Braun Medical, Inc., Apr. 2007. |
Phaseal, The PhaSeal® Solution, http://www.phaseal.com/siteUS/page.asp?menuitem=145&right=0, dated Jan. 9, 2006. |
Phaseal, How to Use PhaSeal®, http://www.phaseal.com/siteUS/movies.asp?main=filmsmain&right=filmsright, dated Jul. 25, 2005. |
“Protection Safety Products”, IV Sets and Access Devices Medication Delivery Catalog, Chemo-Aide Dispensing Pin, Dec. 2002, pp. 7,21, Baxter Healthcare Corporation, Round Lake, IL. |
Spiros—Closed Male Luer. 2-page brochure. Jan. 2012 ICU Medical, Inc. (M1-1184 Rev. 11). |
Number | Date | Country | |
---|---|---|---|
20190117515 A1 | Apr 2019 | US |
Number | Date | Country | |
---|---|---|---|
62014872 | Jun 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15384078 | Dec 2016 | US |
Child | 16223499 | US | |
Parent | PCT/US2015/036305 | Jun 2015 | US |
Child | 15384078 | US |